The problem with standard supplements
Every supplement on the shelf is formulated for a statistical average. "Adults need 600–2000 IU of vitamin D daily." "Recommended magnesium: 300–400 mg." These numbers are population means, useful for public health guidance and useless for calibrating an individual's biology.
The variance around those means is enormous. VDR polymorphisms cause a 2–3x difference in effective vitamin D requirements between individuals with identical serum levels. Two people can have the same blood test result and require completely different doses to achieve the same cellular outcome. Generic supplements can't account for that. They don't know which person you are.
The same pattern applies across dozens of nutrient pathways. Your genetics determine not just how much you need, but what molecular forms you can actually use, and that's the gap standard supplements leave entirely unaddressed.
What nutrigenomics actually is
Nutrigenomics examines how genetic variants, single nucleotide polymorphisms (SNPs) in specific genes, affect how your body processes nutrients. It's not a fringe field. The foundational research has been published in journals including Nature Genetics, The American Journal of Clinical Nutrition, and The Journal of Human Genetics, with thousands of peer-reviewed studies documenting specific gene-nutrient relationships.
The key distinction from "DNA diet" services is what the research actually supports. Predicting optimal macronutrient ratios from genetics has weak evidence. Predicting how specific micronutrient pathways function (absorption, conversion, utilisation) has strong, replicable evidence. MyGNLab stays in the latter category.
The genetic markers we actually analyse
Your report covers 57 genetic markers across 48 genes. Every one is listed below with its variant ID, so you can look up the research yourself rather than taking our word for it.
We only list what we measure. If a gene isn't here, we don't test it.
Micronutrient handling
Vitamin D: how well your cells respond
Vitamin D only works once it binds the vitamin D receptor inside your cells, which then switches on hundreds of downstream genes. The VDR gene builds that receptor. Four well-studied variants (FokI, BsmI, ApaI and one regulatory site) change how efficiently it responds, so two people with identical blood levels can get different biological effects from the same dose. Reduced-response genotypes need a higher level to reach the same activity. Jia et al., Genet Test Mol Biomarkers, 2013 (meta-analysis of 26 studies); Krasniqi et al., Nutrients, 2021 (systematic review, 77 studies).
Folate: whether folic acid is usable for you
MTHFR builds the enzyme that converts folic acid into methylfolate, the only form your body can put to work. Carry two copies of the 677T variant and that enzyme runs at roughly a third of normal speed. The folic acid in a standard multivitamin largely sits there unconverted. Methylfolate skips the broken step entirely, which is why your formula uses 5-MTHF rather than folic acid when your genotype calls for it. Tsang et al., Am J Clin Nutr, 2015 (systematic review and meta-analysis); Colson et al., Eur J Nutr, 2017.
Homocysteine: recycling it back to methionine
MTHFR and MTRR work with folate, B12, B6 and B2 to convert homocysteine back into methionine. Reduced-function variants slow that cycle, so homocysteine can drift upward on an ordinary diet. In a meta-analysis of 11,162 coronary heart disease cases against 12,758 controls, the 677TT genotype carried about 16% higher odds of coronary heart disease. The response is the active B-vitamin forms matched to genotype, rather than the same B-complex for everyone. Klerk et al., JAMA, 2002; Bouzidi et al., Sci Rep, 2020; García-Minguillán et al., Genes Nutr, 2014 (riboflavin status modifies the effect).
Iron: when more is the wrong answer
HFE regulates how much iron you absorb from food, through its control of hepcidin. Overload variants release that brake, so iron accumulates in the liver, heart and pancreas. This is one of the few markers where the recommendation flips completely: if you carry these variants, your formula leaves iron out and the sensible next step is a ferritin test, not a supplement. Feder et al., Nature Genetics, 1996; Adams et al., NEJM, 2005.
Selenium: how much you need to run your defences
GPX1 builds a selenium-dependent enzyme that breaks down hydrogen peroxide and lipid hydroperoxides. The rs1050450 variant changes how efficiently that enzyme responds to the selenium available to it, and the genotype difference shows up most clearly when selenium intake is on the low side. A randomised controlled trial found the rise in glutathione peroxidase activity after selenium supplementation depended on which genotype you carry. Miller et al., Am J Clin Nutr, 2012 (randomised controlled trial); Combs et al., Br J Nutr, 2011; Donadio et al., Clin Nutr, 2018 (SU.BRA.NUT).
Coenzyme Q10: whether you can activate it
Q10 is only useful in its reduced form, ubiquinol. NQO1 performs that conversion. The rs1800566 variant destabilises the protein so it breaks down quickly inside the cell, and homozygous carriers have close to no functional enzyme. Around 9% of people carry the reduced-function version. For them, loading up on standard ubiquinone Q10 is poor value, and the formula routes around it with vitamins C and E, selenium and alpha-lipoic acid instead. Ross et al., Chem Biol Interact, 2000; Fischer et al., BMC Res Notes, 2011 (54 healthy men, ubiquinol 150 mg/day for 14 days); Freriksen et al., J Hum Genet, 2014.
Lactose, and the calcium problem underneath it
This variant decides whether you keep producing lactase into adulthood. The interesting part isn't the intolerance, it's what happens next. People who cut dairy without replacing it commonly end up short on calcium, because dairy was doing most of that work. Your formula adjusts calcium accordingly. Enattah et al., Nature Genetics, 2002.
Fats and cholesterol
Omega-3: the variant that reverses the effect
APOA1 builds the main HDL protein. In the Framingham study, women carrying the A allele had roughly 13% higher HDL cholesterol on a high polyunsaturated fat intake, while carriers of the common GG genotype (about two thirds of people) saw little to no HDL benefit from omega-3. In some carriers the response goes the other way and omega-3 lowers HDL. Where that applies, phytosterols do the cholesterol work instead. Ordovas et al., Am J Clin Nutr, 2002 (Framingham Study); de Luis et al., J Diabetes Complications, 2019; Ras et al., Br J Nutr, 2014 (plant sterols meta-analysis).
LDL cholesterol regulation
APOE builds the docking site that lets LDL particles be pulled out of circulation by the liver. APOB is the particle's own recognition protein. SREBF2 acts as the traffic controller for the wider cholesterol-regulation network. Variants across these three change how effectively LDL is cleared from the blood, which shapes how much dietary cholesterol and saturated fat matter for you specifically.
Triglyceride regulation
APOA5 influences how quickly triglycerides are cleared after a meal. Variants here are associated with higher fasting triglycerides and a stronger response to dietary fat and alcohol, which feeds into the fat and omega-3 side of your recommendations.
Oxidative stress and detoxification
Your antioxidant defence chain
About 5% of the oxygen your cells take up ends up as superoxide and related reactive species. Clearing it takes a relay: SOD2 turns superoxide into hydrogen peroxide, GPX1 turns that into water, and the glutathione S-transferases mop up the oxidised leftovers. The SOD2 rs4880 variant makes the enzyme harder to import into mitochondria where it's needed. GSTM1 and GSTT1 are commonly deleted outright, meaning no enzyme is produced at all. Weak links in this chain are why two people eating the same diet can hold very different antioxidant reserves. Sutton et al., Pharmacogenetics, 2003; Sørensen et al., Mech Ageing Dev, 2009; Wenzlaff et al., Carcinogenesis, 2004.
Clearing combustion products from grilled and smoked food
Grilling, smoking and charring produce polycyclic aromatic hydrocarbons. Phase I enzymes, CYP1A1 and CYP1B1, chemically activate them first, turning them into reactive intermediates that phase II is then supposed to neutralise. The CYP1B1 Val432 variant can run up to three times faster than the reference version. Fast phase I paired with slow phase II leaves those intermediates hanging around longer. The practical response is gentler cooking plus cruciferous vegetables and their sulforaphane to push phase II along. Wu et al., PLoS One, 2013 (meta-analysis); Lao et al., Lung, 2014; Shi et al., Mol Pharmacol, 2010.
Handling everyday chemical exposure
Glutathione S-transferases tag reactive chemicals with glutathione so they can be excreted. A large share of people carry a complete deletion of GSTM1 or GSTT1, which means that enzyme simply isn't there. Studies across agricultural, industrial and urban groups consistently find null carriers show more exposure-related oxidative stress from pesticides, solvents and particulates. Your formula leans harder on glutathione support and antioxidants when this applies. Ghelli et al., Toxics, 2021; Sun et al., Environ Pollut, 2021; Barrón Cuenca et al., Sci Total Environ, 2019.
Inflammation, blood pressure and stimulants
Your inflammatory set point
These variants sit in the promoter and receptor regions of the main inflammatory signalling genes, and they change how much cytokine you produce for a given trigger. A joint analysis of 21 studies covering more than 20,000 adults of European ancestry examined the IL6 -174 variant alone. If you carry the higher-output combinations, an anti-inflammatory intake (omega-3, polyphenols, adequate vitamin D, zinc) is a long-term lever worth taking seriously rather than a nice-to-have. Fishman et al., J Clin Invest, 1998; Huth et al., Diabetes, 2006 (21 studies, >20,000 adults); Norde et al., Clin Nutr, 2018 (gene-fatty acid interaction).
Salt sensitivity and blood pressure
AGT sits in the renin-angiotensin system that controls blood pressure and fluid balance. GNB3 affects the cellular signalling behind sodium handling. In a population study using urinary sodium, the slope between systolic blood pressure and sodium intake was about twice as steep in risk-allele carriers as in reference-allele homozygotes. In the DASH trial, genotype groups separated clearly on blood-pressure response to a low-sodium diet. Knowing which group you're in turns "eat less salt" from generic advice into a specific one. Norat et al., Am J Clin Nutr, 2008; Svetkey et al., J Hypertens, 2001 (DASH); Hunt et al., Hypertension, 1998 (TOHP-II).
Caffeine: fast or slow, and why it matters
One liver enzyme handles more than 90% of the caffeine you drink, and this single variant sets its speed. Roughly 41% of people are fast metabolisers, 44% sit in the middle, and 15% are slow. The research is unusually clean here: in slow metabolisers under 59 drinking four or more cups a day, the odds of myocardial infarction were more than doubled, while fast metabolisers showed no such association and in some analyses were protected. Same coffee, different biology. Cornelis et al., JAMA, 2006; Palatini et al., J Hypertens, 2009; Mahdavi et al., JAMA Netw Open, 2023; Sachse et al., Br J Clin Pharmacol, 1999.
Also in your panel
Metabolism, bone, connective tissue and vascular genes
Alongside the chapters above, your report genotypes: FTO (rs9939609) and PPARG (rs1801282) for appetite and fat storage, ADRB1 (rs1801253) for adrenergic signalling, TCF7L2 (rs7903146), KCNJ11 (rs5219), HHEX (rs1111875) and HIGD1C (rs12304921) for glucose handling, PON1 (rs662, rs854560) for lipid oxidation, COL1A1 (rs1800012) and ESR1 (rs2234693) for bone and connective tissue, MMP3 for tissue remodelling, HLA-DQA1 (rs2187668) and HLA-DQ8 (rs7454108) for gluten-related risk, ITGB3 (rs5918) and GJA4 (rs1764391) for platelet and vascular function, CFH (rs1061170), ARMS2 (rs10490924) and HTRA1 (rs11200638) for eye health and lutein need, plus two vascular loci at rs8055236 and rs1333049.
These feed the totals for individual nutrients. Vitamin E, for example, is calculated from your Q10 chapter, your oxidative stress chapter and this additional set combined, rather than from one gene in isolation.
What the research supports, and what it doesn't
MyGNLab is transparent about where the science is strong and where it continues to evolve.
Strong evidence, what we build from
- Micronutrient form selection: Which molecular forms (methylfolate vs folic acid, D3 vs D2, magnesium glycinate vs oxide) your variants can effectively use. Well-characterised across hundreds of studies.
- Direction of effect: Whether a given variant increases or decreases your requirement for a specific nutrient. Consistently replicated in independent cohorts.
- Nutrient interactions: Which nutrients compete for absorption (calcium + iron, zinc + copper) and which are synergistic, which matters for timing and combining in a sachet.
Emerging, included with caveats
- Precise dosing thresholds: Most research confirms direction of effect reliably. Exact optimal doses from multi-variant combinations are actively researched. MyGNLab uses validated ranges, not single-point doses.
- Multi-gene interaction modelling: Most published studies are single-gene. Real biology involves multiple interacting variants. Our models are built on published interaction data where available, with conservative defaults where not.
Not supported, what we don't do
- DNA-based macronutrient ratios ("your genotype suggests low-carb"). Evidence for this is weak and not reproducible in large trials.
- Disease prediction or diagnostic claims. MyGNLab is a nutrition company, not a medical diagnostics company.
- Guaranteed outcomes. Biology is complex. Your formula is built on the best available evidence, and we update our models as the field advances.
Why the delivery format matters as much as the formula
Getting the right nutrients in the right forms is only half the problem. Getting them into your cells is the other half.
Standard capsules dissolve in the stomach, releasing everything at once. Gastric acid destroys a significant portion of active ingredients before they reach the small intestine where absorption occurs. Competing nutrients (calcium and iron, zinc and copper) block each other's absorption transporters when they arrive simultaneously.
MyGNLab uses microencapsulated pellets, individually coated nutrient particles that release at different points in the digestive tract. Synergistic nutrients are timed to arrive together. Competing nutrients are timed apart. Fat-soluble vitamins release in the small intestine where bile acids are available to aid absorption. Water-soluble nutrients release earlier. The result is measurably better delivery compared to standard capsule formats.
The laboratory
DNA analysis is performed by a European genetics laboratory in Austria that has been running since 2009. It works under ISO 9001 quality management, holds CLIA certification and an Austrian licence for medical genetic analyses, and manufactures under ISO 22000. Samples are processed inside the EU under GDPR and are never sent abroad.
Your saliva sample undergoes targeted genotyping of 57 markers across 48 genes. The analysis returns your specific variant call for every marker, and MyGNLab's formulation engine turns those calls into nutrient doses. Each chapter of your report shows the genotype behind it, so the recommendation and its evidence sit on the same page.
Your genetic data is stored under GDPR, used exclusively for your supplement formulation, and never shared with third parties for research, advertising, or any other purpose. You can request deletion at any time.
Go deeper, gene by gene
Every marker in your report has a real gene behind it. These pages cover the eight that change your formula most: what the gene does, which variant we read, and what it means in practice.
Why folic acid does not work the same for everyone
Two copies of the 677T variant leaves about a third of normal enzyme activity, so standard folic acid largely sits there unconverted.
Read →Why the same vitamin D dose lands differently
Vitamin D works by binding a receptor. Four common variants change how well that receptor responds, so identical blood levels do different amounts of work.
Read →Whether coffee is working for you or against you
One enzyme clears more than 90% of your caffeine. 15% of people are slow metabolisers, and the coffee research separates sharply along that line.
Read →The gene that flips the iron advice
Overload variants release the brake on iron absorption. For carriers, more iron is the wrong answer and a ferritin test is the right one.
Read →Why CoQ10 does very little for 9% of people
CoQ10 only works once reduced to ubiquinol. One variant leaves homozygotes with almost no enzyme to do it.
Read →The variant that can reverse what omega-3 does
Around two thirds of people get almost no HDL benefit from omega-3. In some the direction reverses entirely.
Read →How much selenium you actually need
A selenium-dependent enzyme whose response to intake depends on genotype, most visibly where baseline selenium is low.
Read →Whether salt actually moves your blood pressure
In risk-allele carriers the blood-pressure response to sodium is about twice as steep. For everyone else salt is a smaller lever.
Read →Our blog also covers genetics that isn't in the panel, such as histamine clearance and muscle-fibre type. Those posts say so at the top.
The literature behind each chapter
Every chapter in your report sits on a written literature review of the published human research for that gene. Thirteen reviews, 205 peer-reviewed references between them. Here's what covers what.
| Review | Genes covered | References |
|---|---|---|
| Cytokine pathways and inflammatory responsiveness | TNFA, IL6, IL6R, IL1A, IL1B, CRP | 34 |
| Antioxidant defence against free radicals | GSTM1, GSTT1, GSTP1, SOD2, GPX1 | 33 |
| Detoxification of combustion-derived pollutants | CYP1A1, CYP1B1 | 25 |
| Detoxification of environmental chemicals | GSTM1, GSTT1, GSTP1 | 25 |
| MTHFR and MTRR in homocysteine regulation | MTHFR, MTRR | 15 |
| Genetic determinants of vitamin D status and VDR signalling | VDR | 14 |
| CYP1A2 genotype and the health effects of coffee | CYP1A2 | 13 |
| Salt intake, blood pressure and the AGT locus | AGT, GNB3 | 12 |
| APOA1 promoter variation and HDL response to omega-3 | APOA1 | 9 |
| MTHFR variation and the case for L-methylfolate | MTHFR | 8 |
| GPX1 variation and selenium requirement | GPX1 | 7 |
| Catecholamine-driven lipolysis and caloric restriction | ADRB2 | 6 |
| NQO1 in the antioxidant activation of Coenzyme Q10 | NQO1 | 4 |
These are literature reviews, not clinical trials we ran. They summarise what other researchers have published, including the parts where the evidence is thinner than we'd like. Where a review says the effect is modest, we say so too.
Ready to see what your DNA says?
One test. One formula. Built from your actual biology, not a population average.
Get started